Connecting the Dots: Heat, Disease, and the Future of Climate-Health Action

Why integrated risk, catalytic financing, and system-level thinking are key to scaling climate-health solutions

Building on our previous insights, the next phase of action lies in connecting the dots—between climate signals and health outcomes, between innovation and implementation, and between risk and response. As the climate x health landscape evolves, the focus must shift from understanding the problem to operationalizing integrated solutions that can work at scale. This requires both a systems-level view of interconnected risks and new approaches to financing that can unlock and sustain impact.

Building the bridge: CxH- Heat-VBD-Heat-Infectious diseases-Health

One of the clearest insights from IHF’s work is that climate and health are not linked through isolated pathways, but through a set of interconnected, reinforcing loops. Heat, vector-borne diseases (VBDs), and infectious diseases do not operate independently—they are part of a continuum of risk, shaped by environmental changes and mediated through health systems.

At the center of this bridge is heat – often the most immediate and visible manifestation of climate change. However, its impact extends far beyond heat stress and mortality. Rising temperatures influence vector ecology, altering the breeding, survival, and transmission patterns of diseases such as dengue and malaria. Warmer and more humid conditions are expanding the geographical and seasonal spread of VBDs, exposing new populations and straining unprepared health systems.

Heat also interacts with infectious diseases in less direct but equally significant ways. Extreme temperatures can:

  • Weaken immune responses and increase susceptibility to infections
  • Disrupt water and sanitation systems, increasing the risk of water-borne diseases
  • Affect health-seeking behavior and service delivery, delaying diagnosis and treatment


At the same time, environmental changes such as flooding, changing rainfall patterns, and urban heat islands further compound these risk – creating conditions where multiple disease burdens overlap and intensify.

What emerges is not a set of separate challenges, but a linked risk architecture, where climate drivers cascade across health outcomes. Yet, current systems often respond in silos—heat action plans, vector control programs, and infectious disease strategies are designed and implemented independently, limiting their effectiveness.

Building this bridge, therefore, requires a shift in how problems are framed and addressed.

IHF’s approach is to move towards integrated risk management, where:

  • Climate signals (temperature, rainfall, humidity) are linked with disease surveillance systems
  • Early warning systems trigger coordinated health responses across programs
  • Interventions are designed to address co-morbid and compounding risks, rather than single diseases


For instance, integrating heat alerts with vector surveillance data can enable anticipatory action such as targeted vector control, community advisories, and health system preparedness in high-risk geographies.

Ultimately, the goal is to move from fragmented responses to a system(s)-level understanding of climate-sensitive health risks—where heat is not just an endpoint, but a trigger within a broader network of health impacts.

By building these bridges across domains, IHF is helping shape a more cohesive and forward-looking response—one that recognizes climate change not as a series of isolated events, but as a structural force reshaping public health.

Catalytic financing in CxH space

IHF’s experience in the climate–health (CxH) space has underscored that the challenge is not just identifying solutions but unlocking the right kind of capital at the right stage. Traditional funding approaches, whether early- stage grants or large-scale program financing, often fail to support innovations through their most critical phase: the transition from proof of concept to system-wide adoption.

This is where catalytic financing becomes essential.

In the CxH space, many promising solutions sit in a “missing middle.” They have demonstrated technical viability but require support for real-world validation, integration into public systems, and evidence generation at scale. These are inherently high-risk stages, often overlooked by both philanthropy (which may remain pilot-focused) and commercial capital (which seeks clearer returns and scale).

Catalytic capital plays a bridging role—absorbing early risks to unlock downstream investment and adoption.

IHF’s approach to catalytic financing is shaped by three key principles:

1. De-risking innovation for scale

Rather than funding innovation in isolation, the focus is on supporting solutions through:

  • Field validation in diverse, real-world settings
  • Alignment with government priorities and workflows
  • Generation of evidence that enables adoption by larger funders and public systems


2. Anchoring investments in use-cases, not just technologies

Catalytic financing is most effective when tied to clearly defined problem statements—for example, heat risk management for vulnerable populations or climate-sensitive disease surveillance—rather than broad thematic areas. This ensures that funding is directed toward outcome-oriented solutions with a pathway to impact.

3. Leveraging partnerships to crowd-in capital

Catalytic funding is not intended to operate at scale alone. Instead, it is used to:

  • Signal credibility to governments and larger donors
  • Enable co-financing and partnerships
  • Create pathways for replication and scale across geographies


Beyond financial capital, IHF has also learned that catalytic support must be accompanied by non-financial enablers—including technical assistance, ecosystem convening, and policy engagement. These elements are often critical in ensuring that innovations move beyond pilots and become embedded within health systems.

Ultimately, catalytic financing in the CxH space is about unlocking momentum—supporting solutions at inflection points where timely, flexible capital can determine whether an innovation remains a pilot or evolves into a scalable, system-level intervention.

As the climate–health field continues to mature, such approaches will be critical in shaping a pipeline of solutions that are not only innovative, but also deployable, scalable, and aligned with public health priorities.

Author:

Archita Chaudhary, Senior Manager – Portfolio, India Health Fund

Publication Date: 14th May, 2026